Top Sell
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Trevena Inc. | 2 | 14 | 0 | 0 | €0.40 | €6.48 | 1520.500% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.86 | €5.51 | 539.745% |
| Sage Therapeutics Inc. | 5 | 3 | 0 | 0 | €11.20 | €26.71 | 138.525% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.64 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.89 | €6.49 | 627.237% |
| Evotec SE | 4 | 1 | 1 | 0 | €8.95 | €16.00 | 78.771% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Ionis Pharmaceuticals Inc. | 20 | 5 | 1 | 0 | €34.37 | €56.86 | 65.441% |
| Immuron | 0 | 1 | 0 | 0 | €1.99 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.25 | €8.27 | 154.345% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.28 | - | - |
| Medigene AG | 1 | 2 | 0 | 0 | €1.22 | €1.00 | -17.695% |
| Arca Biopharma | 0 | 21 | 0 | 0 | €3.12 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €10.40 | €22.00 | 111.538% |
| Acadia Pharmaceuticals | 28 | 1 | 0 | 0 | €14.03 | €31.78 | 126.625% |
| Bristol-Myers Squibb | 11 | 3 | 0 | 0 | €38.02 | €67.64 | 77.927% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.00 | €50.00 | 38.889% |
| Cytomx Therapeutics Inc | 1 | 1 | 0 | 0 | €1.62 | €50.00 | 2990.235% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.87 | - | - |
| Moleculin Biotech Inc | 3 | 25 | 0 | 0 | €0.41 | €18.42 | 4393.659% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.16 | - | - |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €36.85 | 8804.785% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.08 | - | - |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.80 | €7.00 | 2.941% |